Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)

CUSIP: 05153U107

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 7 signals
Share change
+41,992,987
Put/Call ratio
1014%
SEC-reported price per share
$7.10
Number of holders
146
Value change
+$301,096,905
Number of buys
92
Open additional details 1 more signal available
Number of sells
41
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
102,918,451

Security key

05153U107

Report period

Q2 2026

Institutions

146

Top holders

10

Ownership snapshot

Top reported holders of AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TCG Crossover GP II, LLC
Disclosed value leader
Adage Capital Management,...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: TCG Crossover GP II, LLC Showing 1-6 of 15 holder rows.

Quick read

TCG Crossover GP II, LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TCG Crossover GP II, LLC's linked filing trail.
Comparable ownership Top 5
TCG Crossover GP II, LLC 9.9%
Adage Capital Management, L.P. 8.4%
MONTANOVA CAPITAL, LLC 7.6%
Frazier Life Sciences Public Fund... 5.6%
Long Focus Capital Management, LLC 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TCG Crossover GP II, LLC
13D/G
Chen Yu
9.9%
$64,540,664
9,533,333 shares
$0 05 May 2026
Adage Capital Management, L.P.
13D/G
8.4%
$64,640,487
9,104,294 shares
$0 30 Jun 2026
MONTANOVA CAPITAL, LLC
13D/G 13F
Suvretta Capital Management, LLC · Company
7.6%
$30,091,360
4,701,775 shares
+$10,524,518 30 Jun 2025
Frazier Life Sciences Public Fund, L.P.
13D/G
5.6%
$41,231,546
5,807,260 shares
+$12,603,920 30 Jun 2026
Long Focus Capital Management, LLC
13D/G 13F
Company
4.9%
$36,349,032
5,119,582 shares
+$12,780,000 30 Jun 2026
BlackRock, Inc.
13D/G 13F
Company
4.4%
$32,536,212
4,582,436 shares
+$8,849,753 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
146
Shares
95,385,877
Rows available
146
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q4 2025 Across Filers

Q4 2025 holders
116
Q2 2026 holders
146
Holder diff
30
Investor Q4 2025 Shares Q2 2026 Shares Share Diff Share Chg % Q4 2025 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .